These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37289024)

  • 21. The functional interplay of transcription factors and cell adhesion molecules in experimental myelodysplasia including hematopoietic stem progenitor compartment.
    Daw S; Law S
    Mol Cell Biochem; 2021 Feb; 476(2):535-551. PubMed ID: 33011884
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Muench DE; Ferchen K; Velu CS; Pradhan K; Chetal K; Chen X; Weirauch MT; Colmenares C; Verma A; Salomonis N; Grimes HL
    Blood; 2018 Nov; 132(21):e24-e34. PubMed ID: 30249787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lrp5 and Lrp6 are required for maintaining self-renewal and differentiation of hematopoietic stem cells.
    Liu J; Cui Z; Wang F; Yao Y; Yu G; Liu J; Cao D; Niu S; You M; Sun Z; Lian D; Zhao T; Kang Y; Zhao Y; Xue HH; Yu S
    FASEB J; 2019 Apr; 33(4):5615-5625. PubMed ID: 30668923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kmt2c mutations enhance HSC self-renewal capacity and convey a selective advantage after chemotherapy.
    Chen R; Okeyo-Owuor T; Patel RM; Casey EB; Cluster AS; Yang W; Magee JA
    Cell Rep; 2021 Feb; 34(7):108751. PubMed ID: 33596429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematopoietic stem cells preferentially traffic misfolded proteins to aggresomes and depend on aggrephagy to maintain protein homeostasis.
    Chua BA; Lennan CJ; Sunshine MJ; Dreifke D; Chawla A; Bennett EJ; Signer RAJ
    Cell Stem Cell; 2023 Apr; 30(4):460-472.e6. PubMed ID: 36948186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor 2 modulates murine hematopoietic stem cell maintenance through upregulation of p57.
    Thomas DD; Sommer AG; Balazs AB; Beerman I; Murphy GJ; Rossi D; Mostoslavsky G
    Exp Hematol; 2016 May; 44(5):422-433.e1. PubMed ID: 26872540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cell concepts in myelodysplastic syndromes: lessons and challenges.
    Woll PS; Jacobsen SEW
    J Intern Med; 2021 May; 289(5):650-661. PubMed ID: 33843081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression.
    Magee JA; Ikenoue T; Nakada D; Lee JY; Guan KL; Morrison SJ
    Cell Stem Cell; 2012 Sep; 11(3):415-28. PubMed ID: 22958933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mesenchymal stem cells improve cholestatic liver fibrosis by targeting ULK1 to regulate autophagy through PI3K/AKT/mTOR pathway.
    Huang T; Zhang C; Shang Z; Shuai Q; Nie L; Ren J; Hou S; Xie J
    Stem Cells Transl Med; 2024 Jul; 13(7):648-660. PubMed ID: 38736295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individual hematopoietic stem cells in human bone marrow of patients with aplastic anemia or myelodysplastic syndrome stably give rise to limited cell lineages.
    Katagiri T; Kawamoto H; Nakakuki T; Ishiyama K; Okada-Hatakeyama M; Ohtake S; Seiki Y; Hosokawa K; Nakao S
    Stem Cells; 2013 Mar; 31(3):536-46. PubMed ID: 23316019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.
    Will B; Zhou L; Vogler TO; Ben-Neriah S; Schinke C; Tamari R; Yu Y; Bhagat TD; Bhattacharyya S; Barreyro L; Heuck C; Mo Y; Parekh S; McMahon C; Pellagatti A; Boultwood J; Montagna C; Silverman L; Maciejewski J; Greally JM; Ye BH; List AF; Steidl C; Steidl U; Verma A
    Blood; 2012 Sep; 120(10):2076-86. PubMed ID: 22753872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutive MAP kinase activation in hematopoietic stem cells induces a myeloproliferative disorder.
    Chung E; Hsu CL; Kondo M
    PLoS One; 2011; 6(12):e28350. PubMed ID: 22164275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway.
    Xiu AY; Ding Q; Li Z; Zhang CQ
    Drug Des Devel Ther; 2021; 15():3643-3659. PubMed ID: 34456560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mir-215-5p induces autophagy by targeting PI3K and activating ROS-mediated MAPK pathways in cardiomyocytes of chicken.
    Cai J; Yang J; Liu Q; Gong Y; Zhang Y; Zheng Y; Yu D; Zhang Z
    J Inorg Biochem; 2019 Apr; 193():60-69. PubMed ID: 30684759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia.
    Watson AS; Mortensen M; Simon AK
    Cell Cycle; 2011 Jun; 10(11):1719-25. PubMed ID: 21512311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGFBPrP1 accelerates autophagy and activation of hepatic stellate cells via mutual regulation between H19 and PI3K/AKT/mTOR pathway.
    Huang TJ; Ren JJ; Zhang QQ; Kong YY; Zhang HY; Guo XH; Fan HQ; Liu LX
    Biomed Pharmacother; 2019 Aug; 116():109034. PubMed ID: 31152924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelodysplastic syndrome hematopoietic stem cell.
    Li J
    Int J Cancer; 2013 Aug; 133(3):525-33. PubMed ID: 23047726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice.
    Pang WW; Czechowicz A; Logan AC; Bhardwaj R; Poyser J; Park CY; Weissman IL; Shizuru JA
    Blood; 2019 May; 133(19):2069-2078. PubMed ID: 30745302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
    Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
    Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.
    Song SJ; Ito K; Ala U; Kats L; Webster K; Sun SM; Jongen-Lavrencic M; Manova-Todorova K; Teruya-Feldstein J; Avigan DE; Delwel R; Pandolfi PP
    Cell Stem Cell; 2013 Jul; 13(1):87-101. PubMed ID: 23827711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.